(Q38243611)

English

Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

31 August 2017

Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis (English)

1 reference

stated in

Europe PubMed Central

31 August 2017

0 references

Marco Morsch

2

0 references

William Daniel Phillips

object named as

William D Phillips

series ordinal

3

0 references

author name string

Stephen W Reddel

series ordinal

1

1 reference

stated in

Europe PubMed Central

31 August 2017

1 October 2014

1 reference

stated in

Europe PubMed Central

31 August 2017

Current Opinion in Neurology

1 reference

stated in

Europe PubMed Central

31 August 2017

27

1 reference

stated in

Europe PubMed Central

31 August 2017

5

1 reference

stated in

Europe PubMed Central

31 August 2017

558-565

1 reference

stated in

Europe PubMed Central

31 August 2017

A retrospective study of complications of therapeutic plasma exchange in myasthenia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Safety of plasmapheresis in the treatment of neurological disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Managing the risks of immunosuppression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Response to therapy in myasthenia gravis with anti-MuSK antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle specific kinase autoimmune myasthenia gravis in children: a case series

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle specific kinase: organiser of synaptic membrane domains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle-specific receptor tyrosine kinase autoantibodies--a new immunoprecipitation assay

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Clinical and experimental features of MuSK antibody positive MG in Japan.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Myasthenia gravis seronegative for acetylcholine receptor antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

The treatment of Guillain-Barré syndrome by modified plasma exchange--a cost effective method for developing countries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

MuSK-antibody positive myasthenia gravis: questions from the clinic

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

A systematic review of population based epidemiological studies in Myasthenia Gravis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

The search for new antigenic targets in myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Autoantibodies to agrin in myasthenia gravis patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0000000000000136

Identifiers

DOI

10.1097/WCO.0000000000000136

1 reference

stated in

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

PubMed ID

25159928

retrieved

31 August 2017

(Q38243611)

Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)